The effect of cholesterol oxidation products on human platelet aggregation

Thromb Res. 1996 Sep 15;83(6):449-61. doi: 10.1016/0049-3848(96)00154-5.

Abstract

The cholesterol oxidation products (oxysterols) cholest-3,5-diene-7-one, cholestan-5 alpha, 6 alpha-epoxy-3 beta-ol (cholesterol 5 alpha-epoxide), cholestan-5 beta, 6 beta-epoxy-3 beta-ol (cholesterol 5 beta-epoxide), cholest-5-ene-3 beta-ol-7-one (7-ketocholesterol), cholest-5-ene-3 beta, 7 alpha-diol (7 alpha-hydroxycholesterol), cholestan-3 beta, 5 alpha, 6 beta-triol (cholestane triol), and cholest-5-ene-3 beta, 26-diol (27-hydroxycholesterol) potentiated platelet aggregation and increased thromboxane A2 formation in platelets challenged with thrombin, ADP or collagen. These effects were observed at oxysterol concentrations in the range 5-100 microM. Cholesterol 5 beta-epoxide and 7-ketocholesterol increased the mobilization of 3H-arachidonic acid from prelabelled platelet phospholipids in response to thrombin and collagen.

MeSH terms

  • Adenosine Diphosphate / pharmacology
  • Adult
  • Arachidonic Acids / metabolism
  • Cholesterol / analogs & derivatives
  • Cholesterol / chemistry*
  • Collagen / pharmacology
  • Humans
  • Oxidation-Reduction
  • Platelet Aggregation / drug effects*
  • Sterols / pharmacology*
  • Structure-Activity Relationship
  • Thrombin / pharmacology
  • Thromboxane B2 / biosynthesis

Substances

  • Arachidonic Acids
  • Sterols
  • Thromboxane B2
  • Adenosine Diphosphate
  • Collagen
  • Cholesterol
  • Thrombin